The relating factors of metabolic syndrome to benign prostatic hyperplasia

Jae Hun Kim, Bong Suk Shim, Young Sun Hong

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Purpose: Benign prostatic hyperplasia (BPH) is a representative urological disease in men at senescence. The etiology of BPH is multifactorial, with chronic conditions, such as non insulin dependent diabetes mellitus (NIDDM), treated hypertension, obesity, low and high density lipoprotein (HDL) cholesterol levels and high insulin levels, constitute for the development of BPH. The prevalence of metabolic syndrome in a BPH population was investigated and the relationship between BPH and metabolic syndrome evaluated. Materials and methods: The BPH group consisted of 162 patients (63.4± 7.8 years old) diagnosed as BPH and the control group of 68 patients (59.7 ±6.4 years old) without voiding difficulties. In each group, the relating factors, prevalence of BPH and metabolic syndrome were investigated and analyzed for comparison. Results: Comparing the voiding factors of the BPH and control groups, all of the measured values showed aggravation of the voiding difficulty in the BPH compared with the control group. The prevalence of metabolic syndrome in the BPH group was 64.2%, which was about double that in the control group (32.4%) (p<0.001). Among the components of metabolic syndrome, hypertension (70.4%) was found to have the highest prevalence. Conclusions: The probability of patients with BPH having metabolic syndrome is high compared to those without BPH. Consequently, in BPH patients, careful evaluation for metabolic syndrome is needed, with the early diagnosis and proper management of metabolic syndrome should accompany the treatment of BPH.

Original languageEnglish
Pages (from-to)1046-1050
Number of pages5
JournalKorean Journal of Urology
Issue number10
StatePublished - Oct 2005


  • Benign prostatic hyperplasia (BPH)
  • Metabolic syndrome


Dive into the research topics of 'The relating factors of metabolic syndrome to benign prostatic hyperplasia'. Together they form a unique fingerprint.

Cite this